We have demonstrated that STAT3 acts as a trans‐acting factor for MLST8 gene expression and the protein level of mLST8, a core component of mechanistic target of rapamycin complex 1 and 2, positively regulates cap‐dependent translation through 4E‐BP1 phosphorylation in cancer cells. The gene discussed is STAT3; the disease is cancer.